Activins and the Liver
暂无分享,去创建一个
[1] W. Berger,et al. Deregulation of the activin/follistatin system in hepatocarcinogenesis. , 2006, Journal of hepatology.
[2] Sabine Werner,et al. Roles of activin in tissue repair, fibrosis, and inflammatory disease. , 2006, Cytokine & growth factor reviews.
[3] Y. Hasegawa,et al. Analysis of the function of activin betaC subunit using recombinant protein. , 2006, The Journal of reproduction and development.
[4] K. Mutoh,et al. Impaired growth of pancreatic exocrine cells in transgenic mice expressing human activin betaE subunit. , 2006, Biochemical and biophysical research communications.
[5] C. Robinson,et al. Structural basis for the inhibition of activin signalling by follistatin , 2006, The EMBO journal.
[6] D. Endo,et al. Activin or follistatin: which is more beneficial to support liver regeneration after massive hepatectomy? , 2006, Endocrine journal.
[7] Y. Takikawa,et al. Ratio of circulating follistatin and activin A reflects the severity of acute liver injury and prognosis in patients with acute liver failure , 2006, Journal of gastroenterology and hepatology.
[8] D. Phillips,et al. Follistatin attenuates early liver fibrosis: effects on hepatic stellate cell activation and hepatocyte apoptosis. , 2006, American journal of physiology. Gastrointestinal and liver physiology.
[9] T. Jardetzky,et al. Structural Basis for a Functional Antagonist in the Transforming Growth Factor β Superfamily* , 2005, Journal of Biological Chemistry.
[10] A. Mukherjee,et al. Differential biosynthesis and intracellular transport of follistatin isoforms and follistatin-like-3. , 2005, Endocrinology.
[11] C. Donaldson,et al. An Activin-A/C Chimera Exhibits Activin and Myostatin Antagonistic Properties* , 2005, Journal of Biological Chemistry.
[12] H. Kuwano,et al. Adenovirus-mediated overexpression of the activin betaC subunit accelerates liver regeneration in partially hepatectomized rats. , 2005, Journal of hepatology.
[13] N. Seidah,et al. Evidence for proprotein convertase activity in the endoplasmic reticulum/early Golgi , 2005, FEBS letters.
[14] J. Scheerlinck,et al. Activin A: from sometime reproductive factor to genuine cytokine. , 2005, Veterinary immunology and immunopathology.
[15] R. Derynck,et al. SPECIFICITY AND VERSATILITY IN TGF-β SIGNALING THROUGH SMADS , 2005 .
[16] M. Hearn,et al. A molecular recognition paradigm: promiscuity associated with the ligand–receptor interactions of the activin members of the TGF‐β superfamily , 2005, Journal of molecular recognition : JMR.
[17] David Salomon,et al. Cripto-1: a multifunctional modulator during embryogenesis and oncogenesis , 2005, Oncogene.
[18] S. Kloeker,et al. TGF-β inhibitors for the treatment of cancer , 2005 .
[19] K. Tsuchida,et al. Activin and activin receptor expression changes in liver regeneration in rat. , 2005, The Journal of surgical research.
[20] S. Tashiro,et al. Effect of follistatin on rat liver regeneration and tumor growth after portal occlusion. , 2005, Hepato-gastroenterology.
[21] S. Gautam,et al. Inactivation of TGF-β signaling in hepatocytes results in an increased proliferative response after partial hepatectomy , 2005, Oncogene.
[22] H. Kuwano,et al. Comparison of the Function of the βC and βE Subunits of Activin in AML12 Hepatocytes , 2005 .
[23] G. Risbridger,et al. βA- and βC-activin, follistatin, activin receptor mRNA and βC-activin peptide expression during rat liver regeneration , 2005 .
[24] Zhonghui Liu,et al. Effects of activin A on the activities of the mouse peritoneal macrophages. , 2005, Cellular & molecular immunology.
[25] L. Ruddock,et al. The human protein disulphide isomerase family: substrate interactions and functional properties , 2005, EMBO reports.
[26] D. Rifkin,et al. Latent TGF-β binding proteins , 2005 .
[27] H. V. Melchner,et al. TGF-β activation by traction? , 2004 .
[28] C. Schmidt‐Weber,et al. Regulation and role of transforming growth factor-beta in immune tolerance induction and inflammation. , 2004, Current opinion in immunology.
[29] Jonathan M. Yingling,et al. Development of TGF-β signalling inhibitors for cancer therapy , 2004, Nature Reviews Drug Discovery.
[30] Jonas Larsson,et al. Intact signaling by transforming growth factor β is not required for termination of liver regeneration in mice , 2004, Hepatology.
[31] Herbert Y. Lin,et al. Differential actions of follistatin and follistatin-like 3 , 2004, Molecular and Cellular Endocrinology.
[32] D. Phillips,et al. Activin A and follistatin in systemic inflammation , 2004, Molecular and Cellular Endocrinology.
[33] P. Williams,et al. Activin redux: specification of mesodermal pattern in Xenopus by graded concentrations of endogenous activin B , 2004, Development.
[34] T. Waldman,et al. Interaction of the BMPR-IA tumor suppressor with a developmentally relevant splicing factor. , 2004, Biochemical and biophysical research communications.
[35] R. Taub. Liver regeneration: from myth to mechanism , 2004, Nature Reviews Molecular Cell Biology.
[36] S. Choe,et al. A flexible activin explains the membrane-dependent cooperative assembly of TGF-beta family receptors. , 2004, Molecular cell.
[37] H. Kuwano,et al. Assessment of the function of the betaC-subunit of activin in cultured hepatocytes. , 2004, American journal of physiology. Endocrinology and metabolism.
[38] M. O’Bryan,et al. Cell-specific expression of βC-activin in the rat reproductive tract, adrenal and liver , 2004, Molecular and Cellular Endocrinology.
[39] M. Mareel,et al. Melanoma cells secrete follistatin, an antagonist of activin-mediated growth inhibition , 2004, Oncogene.
[40] C. Donaldson,et al. An Activin Mutant with Disrupted ALK4 Binding Blocks Signaling via Type II Receptors* , 2004, Journal of Biological Chemistry.
[41] K. Jones,et al. Characterisation of the rapid release of activin A following acute lipopolysaccharide challenge in the ewe. , 2004, The Journal of endocrinology.
[42] B. Wiedenmann,et al. Activin A stimulates vascular endothelial growth factor gene transcription in human hepatocellular carcinoma cells. , 2004, Gastroenterology.
[43] H. Kuwano,et al. The dependence of transforming growth factor-beta-induced collagen production on autocrine factor activin A in hepatic stellate cells. , 2004, Endocrinology.
[44] K. Patel,et al. Follistatin complexes Myostatin and antagonises Myostatin-mediated inhibition of myogenesis. , 2004, Developmental biology.
[45] D. Phillips,et al. Effect of heparin administration to sheep on the release profiles of circulating activin A and follistatin. , 2004, The Journal of endocrinology.
[46] P. Galle,et al. Cleavage of CD95 by matrix metalloproteinase-7 induces apoptosis resistance in tumour cells , 2004, Oncogene.
[47] A. Ludlow,et al. Latent TGF‐β1 activation by platelets , 2004 .
[48] D. Endo,et al. Activin A augments vascular endothelial growth factor activity in promoting branching tubulogenesis in hepatic sinusoidal endothelial cells. , 2004, Journal of hepatology.
[49] R. Sandler,et al. Loss of activin receptor type 2 protein expression in microsatellite unstable colon cancers. , 2004, Gastroenterology.
[50] A. Roberts,et al. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7. , 2004, Molecular pharmacology.
[51] C. Kemp,et al. Bone morphogenetic protein (BMP) ligands and receptors in bovine ovarian follicle cells: actions of BMP-4, -6 and -7 on granulosa cells and differential modulation of Smad-1 phosphorylation by follistatin. , 2004, Reproduction.
[52] H. Keutmann,et al. The role of follistatin domains in follistatin biological action. , 2004, Molecular endocrinology.
[53] I. Sargent,et al. Endothelial cells and peripheral blood mononuclear cells are a potential source of extraplacental activin a in preeclampsia. , 2003, The Journal of clinical endocrinology and metabolism.
[54] M. Matzuk,et al. Activins are critical modulators of growth and survival. , 2003, Molecular endocrinology.
[55] I. Verma,et al. Adenovirus‐mediated overexpression of follistatin enlarges intact liver of adult rats , 2003, Hepatology.
[56] R. Schulte‐Hermann,et al. Expression of activins C and E induces apoptosis in human and rat hepatoma cells. , 2003, Carcinogenesis.
[57] J. F. Schmitt,et al. Activin betaC-subunit heterodimers provide a new mechanism of regulating activin levels in the prostate. , 2003, Endocrinology.
[58] Mohammad Zafari,et al. Antibody blockade of the Cripto CFC domain suppresses tumor cell growth in vivo. , 2003, The Journal of clinical investigation.
[59] W. Bursch,et al. Induction of apoptosis in mouse liver adenoma and carcinoma in vivo by transforming growth factor-β1 , 2003, Journal of Cancer Research and Clinical Oncology.
[60] K. Herkner,et al. Overexpression of Activin βC or Activin βE in the Mouse Liver Inhibits Regenerative Deoxyribonucleic Acid Synthesis of Hepatic Cells , 2003 .
[61] A. Rademaker,et al. Down-regulation of activin, activin receptors, and Smads in high-grade breast cancer. , 2003, Cancer research.
[62] A. Schneyer,et al. Differential binding and neutralization of activins A and B by follistatin and follistatin like-3 (FSTL-3/FSRP/FLRG). , 2003, Endocrinology.
[63] W. Vale,et al. Cripto forms a complex with activin and type II activin receptors and can block activin signaling , 2003, Proceedings of the National Academy of Sciences of the United States of America.
[64] T. Jardetzky,et al. Structures of an ActRIIB:activin A complex reveal a novel binding mode for TGF‐β ligand:receptor interactions , 2003, The EMBO journal.
[65] C. Redman,et al. Inhibin, activin, follistatin, activin receptors and beta-glycan gene expression in the placental tissue of patients with pre-eclampsia. , 2003, Molecular human reproduction.
[66] Mark Cranfield,et al. Changes in activin and activin receptor subunit expression in rat liver during the development of CCl4-induced cirrhosis , 2003, Molecular and Cellular Endocrinology.
[67] B. Vogelstein,et al. Evidence of selection for clones having genetic inactivation of the activin A type II receptor (ACVR2) gene in gastrointestinal cancers. , 2003, Cancer research.
[68] R. Hughes,et al. Activin A and follistatin in acute liver failure , 2003, European journal of gastroenterology & hepatology.
[69] C. Donaldson,et al. Residues in the C-terminal region of activin A determine specificity for follistatin and type II receptor binding. , 2003, The Journal of endocrinology.
[70] M. Matzuk,et al. Genetic Analysis of the Mammalian Transforming Growth Factor-β Superfamily , 2002 .
[71] R. Schulte‐Hermann,et al. Response of isolated hepatocytes from carcinogen sensitive (C3H) and insensitive (C57BL) mice to signals inducing replication or apoptosis , 2002, Archives of Toxicology.
[72] R. Schulte‐Hermann,et al. Follistatin overexpression in rodent liver tumors: A possible mechanism to overcome activin growth control , 2002, Molecular carcinogenesis.
[73] K. Tsuchida,et al. cDNA cloning and expression of human activin βE subunit , 2002, Molecular and Cellular Endocrinology.
[74] T. Fujita,et al. Involvement of Smad proteins in TGF-beta and activin A-induced apoptosis and growth inhibition of liver cells. , 2002, Hepatology research : the official journal of the Japan Society of Hepatology.
[75] A. Reith,et al. SB-431542 is a potent and specific inhibitor of transforming growth factor-beta superfamily type I activin receptor-like kinase (ALK) receptors ALK4, ALK5, and ALK7. , 2002, Molecular pharmacology.
[76] R. Schulte‐Hermann,et al. Expression and dimerization of the rat activin subunits betaC and betaE: evidence for the ormation of novel activin dimers. , 2002, Journal of molecular endocrinology.
[77] T. Hayakawa,et al. Effect of activins AB and B on DNA synthesis stimulated by epidermal growth factor in primary cultured rat hepatocytes. , 2002, Biological & pharmaceutical bulletin.
[78] R. Schulte‐Hermann,et al. Hepatocytes convert to a fibroblastoid phenotype through the cooperation of TGF-beta1 and Ha-Ras: steps towards invasiveness. , 2002, Journal of cell science.
[79] D. Salomon,et al. Cripto: A tumor growth factor and more , 2002, Journal of cellular physiology.
[80] M. Yuen,et al. Transforming Growth Factor-Beta 1, Activin and Follistatin in Patients with Hepatocellular Carcinoma and Patients with Alcoholic Cirrhosis , 2002, Scandinavian journal of gastroenterology.
[81] P. Heinrich,et al. Cytokines in liver injury and repair , 2002 .
[82] G. Risbridger,et al. Activins and inhibins in endocrine and other tumors. , 2001, Endocrine reviews.
[83] M. Mori,et al. Transforming growth factor β and activin tonically inhibit DNA synthesis in the rat liver , 2001 .
[84] D. Roulot,et al. Transforming growth factor β and the liver , 2001 .
[85] G. Risbridger,et al. Activins as regulators of branching morphogenesis. , 2001, Developmental biology.
[86] J. Kleeff,et al. Overexpression of activin A in stage IV colorectal cancer , 2001, Gut.
[87] A. Schneyer,et al. Human follistatin-related protein: a structural homologue of follistatin with nuclear localization. , 2001, Endocrinology.
[88] H. Keutmann,et al. Follistatin-related protein (FSRP): a new member of the follistatin gene family , 2001, Molecular and Cellular Endocrinology.
[89] M. Hedger,et al. Evidence for activin A and follistatin involvement in the systemic inflammatory response , 2001, Molecular and Cellular Endocrinology.
[90] C. Heldin,et al. Activation of the TGF-beta/activin-Smad2 pathway during allergic airway inflammation. , 2001, American journal of respiratory cell and molecular biology.
[91] P. Billings,et al. Authentic Matrix Vesicles Contain Active Metalloproteases (MMP) , 2001, The Journal of Biological Chemistry.
[92] D. Phillips,et al. Characterization of serum activin-A and follistatin and their relation to virological and histological determinants in chronic viral hepatitis. , 2001, Journal of hepatology.
[93] R. Hruban,et al. ACVR1B (ALK4, activin receptor type 1B) gene mutations in pancreatic carcinoma , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[94] A. Roberts,et al. The hepatitis B virus encoded oncoprotein pX amplifies TGF-beta family signaling through direct interaction with Smad4: potential mechanism of hepatitis B virus-induced liver fibrosis. , 2001, Genes & development.
[95] H. Wei,et al. Expression changes of activin A in the development of hepatic fibrosis. , 2001, World journal of gastroenterology.
[96] E. Montgomery,et al. すい臓癌におけるACVR1B(ALK4、1B型アクチビン受容体)遺伝子の突然変異 , 2001 .
[97] A. Roberts,et al. Suppressor and oncogenic roles of transforming growth factor-beta and its signaling pathways in tumorigenesis. , 2001, Advances in cancer research.
[98] K. Tsuchida,et al. Identification and Characterization of a Novel Follistatin-like Protein as a Binding Protein for the TGF-β Family* , 2000, The Journal of Biological Chemistry.
[99] J E Moreira,et al. Role of the conserved WHXL motif in the C terminus of synaptotagmin in synaptic vesicle docking. , 2000, Proceedings of the National Academy of Sciences of the United States of America.
[100] A. Mason,et al. Localization of activin beta(A)-, beta(B)-, and beta(C)-subunits in humanprostate and evidence for formation of new activin heterodimers of beta(C)-subunit. , 2000, The Journal of clinical endocrinology and metabolism.
[101] M. Matzuk,et al. Activin βC and βE Genes Are Not Essential for Mouse Liver Growth, Differentiation, and Regeneration , 2000, Molecular and Cellular Biology.
[102] T. Hayakawa,et al. Expression of inhibin βA, βB, and follistatin mrnas in the carbon tetrachloride induced rat liver regeneration model , 2000 .
[103] M. O’Bryan,et al. Cloning and regulation of the rat activin betaE subunit. , 2000, Journal of molecular endocrinology.
[104] S. Kanzler,et al. Apoptosis and the liver. , 2000, Seminars in cancer biology.
[105] G. Risbridger,et al. Role of activins in the male reproductive tract. , 2000, Reviews of reproduction.
[106] H. Kuwano,et al. The role of activin and transforming growth factor‐β in the regulation of organ mass in the rat liver , 2000, Hepatology.
[107] K. Matsuzaki,et al. Differential regulation of activin A for hepatocyte growth and fibronectin synthesis in rat liver injury. , 2000, Journal of hepatology.
[108] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[109] F. Petraglia,et al. Evaluation of circulating activin-A as a serum marker of hepatocellular carcinoma. , 2000, Cancer detection and prevention.
[110] M. Mitchell,et al. Activin A exerts both pro- and anti-inflammatory effects on human term gestational tissues. , 2000, Placenta.
[111] R. Balling,et al. Overexpression of activin A in the skin of transgenic mice reveals new activities of activin in epidermal morphogenesis, dermal fibrosis and wound repair , 1999, The EMBO journal.
[112] C. Niehrs,et al. Silencing of TGF-β signalling by the pseudoreceptor BAMBI , 1999, Nature.
[113] M. Ozturk,et al. Smad2 and Smad4 gene mutations in hepatocellular carcinoma , 1999, Oncogene.
[114] T. Ishikawa,et al. Interruption of activin A autocrine regulation by antisense oligodeoxynucleotides accelerates liver tumor cell proliferation. , 1999, Endocrinology.
[115] J. Gurdon,et al. Activin as a morphogen in Xenopus mesoderm induction. , 1999, Seminars in cell & developmental biology.
[116] H. Friess,et al. Transforming growth factor betas and their signaling receptors in human hepatocellular carcinoma. , 1999, American journal of surgery.
[117] D. Constam,et al. Regulation of Bone Morphogenetic Protein Activity by Pro Domains and Proprotein Convertases , 1999, The Journal of cell biology.
[118] H. Shibata,et al. Immediate onset of DNA synthesis in remnant rat liver after 90% hepatectomy by an administration of follistatin. , 1998, Journal of hepatology.
[119] H. Uchiyama,et al. Direct binding of follistatin to a complex of bone-morphogenetic protein and its receptor inhibits ventral and epidermal cell fates in early Xenopus embryo. , 1998, Proceedings of the National Academy of Sciences of the United States of America.
[120] K. Mayo,et al. Structure of the Rat Inhibin and Activin βA-Subunit Gene and Regulation in an Ovarian Granulosa Cell Line. , 1998, Endocrinology.
[121] J. Magaud,et al. FLRG (follistatin-related gene), a new target of chromosomal rearrangement in malignant blood disorders , 1998, Oncogene.
[122] H. Asakura,et al. Expression of activin A is increased in cirrhotic and fibrotic rat livers. , 1998, Gastroenterology.
[123] J. Pedersen,et al. Inhibins, activins, and follistatins: Expression of mRNAs and cellular localization in tissues from men with benign prostatic hyperplasia , 1998, The Prostate.
[124] P. Galle,et al. CD95-induced apoptosis in human liver disease. , 1998, Seminars in liver disease (Print).
[125] Pieter,et al. Localization and cellular sources of activins in normal and fibrotic rat liver , 1997, Hepatology.
[126] H. Schrewe,et al. Reciprocal expression of mRNA for inhibin betaC and betaA subunits in hepatocytes. , 1997, Endocrine journal.
[127] S. Perkins,et al. The Factor I and follistatin domain families: the return of a prodigal son. , 1997, The Biochemical journal.
[128] T. Zimmers,et al. Transient down-regulation of inhibin-betaC expression following partial hepatectomy. , 1997, Biochemical and biophysical research communications.
[129] Y. Hayashi,et al. A Novel Role of Follistatin, an Activin-binding Protein, in the Inhibition of Activin Action in Rat Pituitary Cells , 1997, The Journal of Biological Chemistry.
[130] J. Bonadio,et al. Genes coding for mouse activin beta C and beta E are closely linked and exhibit a liver-specific expression pattern in adult tissues. , 1997, Biochemical and biophysical research communications.
[131] Y. Nibu,et al. Human activin betaA gene. Identification of novel 5' exon, functional promoter, and enhancers. , 1996, The Journal of biological chemistry.
[132] J. Bonadio,et al. Molecular cloning of the mouse activin beta E subunit gene. , 1996, Biochemical and biophysical research communications.
[133] A. Mason,et al. Characterization and determination of the biological activities of noncleavable high molecular weight forms of inhibin A and activin A. , 1996, Molecular Endocrinology.
[134] Irene L Andrulis,et al. MADR2 Maps to 18q21 and Encodes a TGFβ–Regulated MAD–Related Protein That Is Functionally Mutated in Colorectal Carcinoma , 1996, Cell.
[135] K. Loveland,et al. Expression of activin beta C subunit mRNA in reproductive tissues. , 1996, Journal of molecular endocrinology.
[136] M. Matzuk,et al. Structural analysis of the mouse activin beta C gene. , 1996, Biochimica et biophysica acta.
[137] A. Gressner,et al. Transforming growth factor β (TGF‐β) expression in isolated and cultured rat hepatocytes , 1996 .
[138] W. Bursch,et al. Transforming growth factor β1‐induced cell death in preneoplastic foci of rat liver and sensitization by the antiestrogen tamoxifen , 1996, Hepatology.
[139] S. Thorgeirsson,et al. The antiandrogen cyproterone acetate induces synthesis of transforming growth factor β1 in the parenchymal cells of the liver accompanied by an enhanced sensitivity to undergo apoptosis and necrosis without inflammation , 1996 .
[140] Scott E. Kern,et al. DPC4, A Candidate Tumor Suppressor Gene at Human Chromosome 18q21.1 , 1996, Science.
[141] D. Huylebroeck,et al. Follistatins neutralize activin bioactivity by inhibition of activin binding to its type II receptors , 1996, Molecular and Cellular Endocrinology.
[142] M. Merino,et al. Differential immunohistochemical detection of transforming growth factor α, amphiregulin and CRIPTO in human normal and malignant breast tissues , 1996, International journal of cancer.
[143] J. Taipale,et al. Association of the small latent transforming growth factor‐beta with an eight cysteine repeat of its binding protein LTBP‐1. , 1996, The EMBO journal.
[144] D. Steiner,et al. Proteolytic Processing Mechanisms in the Biosynthesis of Neuroendocrine Peptides: The Subtilisin-like Proprotein Convertases , 1995, Frontiers in Neuroendocrinology.
[145] N. Ueno,et al. Molecular cloning and functional analysis of a new activin beta subunit: a dorsal mesoderm-inducing activity in Xenopus. , 1995, Biochemical and biophysical research communications.
[146] R. Leduc,et al. Processing of Transforming Growth Factor 1 Precursor by Human Furin Convertase (*) , 1995, The Journal of Biological Chemistry.
[147] M. Kanzaki,et al. A single intraportal administration of follistatin accelerates liver regeneration in partially hepatectomized rats. , 1995, Gastroenterology.
[148] Jianming Xu,et al. Inhibin Antagonizes Inhibition of Liver Cell Growth by Activin by a Dominant-negative Mechanism (*) , 1995, The Journal of Biological Chemistry.
[149] M. Kanzaki,et al. Derangements in the activin-follistatin system in hepatoma cells. , 1995, Gastroenterology.
[150] M. Kanzaki,et al. Production of activin A and follistatin in cultured rat vascular smooth muscle cells , 1995, Molecular and Cellular Endocrinology.
[151] Mann-Jy Chen,et al. Mapping the Domain(s) Critical for the Binding of Human Tumor Necrosis Factor-α to Its Two Receptors (*) , 1995, The Journal of Biological Chemistry.
[152] D. Robertson,et al. Inhibin forms in human plasma. , 1995, The Journal of endocrinology.
[153] C. Schneider,et al. Cloning of a New Member of the TGF-β Family: A Putative New Activin βC Chain , 1995 .
[154] W. Bursch,et al. Active cell death (apoptosis) in liver biology and disease. , 1995, Progress in liver diseases.
[155] R. Schwall,et al. Induction of apoptosis in the murine liver with recombinant human activin a , 1994, Hepatology.
[156] A. Bradley,et al. Development of cancer cachexia-like syndrome and adrenal tumors in inhibin-deficient mice. , 1994, Proceedings of the National Academy of Sciences of the United States of America.
[157] W. Crowley,et al. Characterization of unique binding kinetics of follistatin and activin or inhibin in serum. , 1994, Endocrinology.
[158] M. Tuite,et al. Protein disulphide isomerase: building bridges in protein folding. , 1994, Trends in biochemical sciences.
[159] K. Hildén,et al. The tissue distribution of activin beta A- and beta B-subunit and follistatin messenger ribonucleic acids suggests multiple sites of action for the activin-follistatin system during human development. , 1994, The Journal of clinical endocrinology and metabolism.
[160] A. Mason. Functional analysis of the cysteine residues of activin A. , 1994, Molecular endocrinology.
[161] E. Allan,et al. Plasminogen‐dependent activation of latent transforming growth factor beta (TGFβ) by growing cultures of osteoblast‐like cells , 1993, Journal of cellular physiology.
[162] J. Vaughan,et al. Characterization and the regulation of inhibin/activin subunit proteins of cultured rat anterior pituitary cells. , 1993, Endocrinology.
[163] N. Fausto. Hepatocyte apoptosis: is transforming growth factor-B1 the kiss of death? , 1993, Hepatology.
[164] T. Mine,et al. Activin A: an autocrine inhibitor of initiation of DNA synthesis in rat hepatocytes. , 1993, The Journal of clinical investigation.
[165] R. Schwall,et al. Activin induces cell death in hepatocytes in vivo and in vitro , 1993, Hepatology.
[166] N. Ling,et al. Molecular heterogeneity of follistatin, an activin-binding protein. Higher affinity of the carboxyl-terminal truncated forms for heparan sulfate proteoglycans on the ovarian granulosa cell. , 1993, The Journal of biological chemistry.
[167] W. Hendrickson,et al. A structural superfamily of growth factors containing a cystine knot motif , 1993, Cell.
[168] J. Vaughan,et al. Alpha 2-macroglobulin is a binding protein of inhibin and activin. , 1993, Endocrinology.
[169] W. Bursch,et al. Transforming growth factor-beta 1 as a signal for induction of cell death by apoptosis. , 1993, British Journal of Cancer.
[170] L. Madisen,et al. Site-directed mutagenesis of glycosylation sites in the transforming growth factor-beta 1 (TGF beta 1) and TGF beta 2 (414) precursors and of cysteine residues within mature TGF beta 1: effects on secretion and bioactivity. , 1992, Molecular endocrinology.
[171] W. Bursch,et al. Induction of apoptosis in cultured hepatocytes and in regressing liver by transforming growth factor beta 1. , 1992, Proceedings of the National Academy of Sciences of the United States of America.
[172] C. Chou,et al. In Vitro Apoptosis in the Human Hepatoma Cell Line Induced by Transforming Growth Factor β1 , 1992 .
[173] J. Findlay,et al. Rat follistatin: ontogeny of steady-state mRNA levels in different tissues predicts organ-specific functions. , 1991, Biochemical and biophysical research communications.
[174] K. Titani,et al. Follistatin, an activin-binding protein, associates with heparan sulfate chains of proteoglycans on follicular granulosa cells. , 1991, The Journal of biological chemistry.
[175] W. Bursch,et al. Effect of transforming growth factor beta on cell death of cultured rat hepatocytes. , 1991, Cancer research.
[176] H. Stunnenberg,et al. Expression and processing of the activin-A/erythroid differentiation factor precursor: a member of the transforming growth factor-beta superfamily. , 1990, Molecular endocrinology.
[177] A. Mason,et al. Requirement for activin A and transforming growth factor--beta 1 pro-regions in homodimer assembly. , 1990, Science.
[178] K. Titani,et al. Activin-binding protein from rat ovary is follistatin. , 1990, Science.
[179] A. Mason,et al. Activin B: precursor sequences, genomic structure and in vitro activities. , 1989, Molecular endocrinology.
[180] A. Brunner,et al. Site-directed mutagenesis of cysteine residues in the pro region of the transforming growth factor beta 1 precursor. Expression and characterization of mutant proteins. , 1989, The Journal of biological chemistry.
[181] A. Brunner,et al. Transforming growth factor beta 1: importance of glycosylation and acidic proteases for processing and secretion. , 1989, Molecular endocrinology.
[182] D. Rifkin,et al. Alpha 2-macroglobulin is a binding protein for basic fibroblast growth factor. , 1989, The Journal of biological chemistry.
[183] R. Coffey,et al. Type beta transforming growth factor reversibly inhibits the early proliferative response to partial hepatectomy in the rat. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[184] N. Ling,et al. Primary structure of the human follistatin precursor and its genomic organization. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[185] W. Russell. Transforming growth factor beta (TGF‐β) inhibits hepatocyte DNA synthesis independently of EGF binding and egf receptor autophosphorylation , 1988, Journal of cellular physiology.
[186] S. S. Huang,et al. Human transforming growth factor beta.alpha 2-macroglobulin complex is a latent form of transforming growth factor beta. , 1988, The Journal of biological chemistry.
[187] N. Ling,et al. Isolation and partial characterization of follistatin: a single-chain Mr 35,000 monomeric protein that inhibits the release of follicle-stimulating hormone. , 1987, Proceedings of the National Academy of Sciences of the United States of America.
[188] N. Ling,et al. A homodimer of the β-subunits of inhibin a stimulates the secretion of pituitary follicle stimulating hormone , 1986 .
[189] Naoto Ueno,et al. Pituitary FSH is released by a heterodimer of the β-subunits from the two forms of inhibin , 1986, Nature.
[190] Joan Vaughan,et al. Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid , 1986, Nature.
[191] N. Ling,et al. Type beta transforming growth factor (TGF-beta) is a potent stimulator of the basal secretion of follicle stimulating hormone (FSH) in a pituitary monolayer system. , 1986, Biochemical and biophysical research communications.
[192] H. Lodish. Molecular Cell Biology , 1986 .
[193] J. Vaughan,et al. Purification and partial characterization of inhibin from porcine follicular fluid. , 1985, Biochemical and biophysical research communications.
[194] D. Robertson,et al. Inhibin: 1985 update on action and purification , 1985, Molecular and Cellular Endocrinology.
[195] M. Sairam,et al. ISOLATION AND CHARACTERIZATION OF INHIBIN FROM HUMAN SEMINAL PLASMA * , 1982, Annals of the New York Academy of Sciences.
[196] A. Sheth,et al. Isolation & characterization of inhibin from human seminal plasma. , 1978, Indian journal of experimental biology.
[197] E. Daume,et al. Purification of "inhibin" from human ovarian follicular fluid. , 1979, Acta endocrinologica.
[198] N. Moudgal,et al. Studies on purification and characterization of sheep testicular inhibin. , 1979, Journal of reproduction and fertility. Supplement.
[199] D. R. Mccullagh. DUAL ENDOCRINE ACTIVITY OF THE TESTES. , 1932, Science.
[200] W. Cramer,et al. ON THE GENERAL EFFECTS OF EXPOSURE TO RADIUM ON METABOLISM AND TUMOUR GROWTH IN THE RAT AND THE SPECIAL EFFECTS ON TESTIS AND PITUITARY , 1923 .